Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer

Inclusion Criteria: * Women ages 65-90 * Chemotherapy treatment for early-stage (I, IIa, IIb, IIIa) breast cancer * Post-menopausal * High school education or greater * Geographically available for followup assessment * Native English speaker * Normal or corrected to near-normal hearing and vision Exclusion Criteria: * Psychiatric history including past or current psychotic spectrum disorders (schizophrenia, bipolar disorder, major depressive disorder, dementia, schizoaffective disorder) * Brain injury (e.g., stroke, heart attack, aneurysm, tumor, concussion, head trauma) * Brain disease * History of brain irradiation or surgery * Current or past disease/disorder of the central nervous system or medical condition affecting cognitive functioning (e.g., chronic migraine, epilepsy or history of seizures, encephalitis, meningitis, multiple sclerosis, thyroid condition, Parkinson's, Alzheimer's, Huntington's disease) * Active diagnosis of autoimmune or inflammatory disorder (e.g., systemic lupus erythematosus, rheumatoid arthritis, vasculitis, insulin-dependent diabetes, Crohn's disease, uncontrolled allergic reaction or asthma) * History of other cancer, except for basal cell carcinoma * Development of a second primary malignancy during the study * Drug or alcohol abuse (i.e., more than 7 drinks per week) * Chronic use of oral steroid medication * Former (prior to early-stage breast cancer) intrathecal therapy, radiation therapy, chemotherapy, or any neoadjuvant chemotherapy * Acquired or developmental speech, language, or learning disorders (e.g., aphasia, dyslexia, dysgraphia, auditory processing disorder, autism, developmental delay) * Hormone replacement therapy, excluding vaginal estrogen